Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Legislation providing more scrutiny for pharmacy benefit managers (PBMs) that failed to make it through Congress in the ...

Carl Schmid, executive director of the HIV+Hepatitis Policy Institute in Washington, D.C., talks about the problems associated with generic HIV PrEP drug markups and potential ways to fix it.

For decades, red light therapy has been an adjunct treatment for numerous ailments. But it may not work for all the medical conditions that supporters say it does.

Managing Director Pakistan Bait-ul-Mal (PBM) in Peshawar, Senator Capt. Shaheen Khalid Butt said that PBM continued to ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

"PBM reform is top of mind with legislators ... including parity in its treatment of drugs that are primarily pills and capsules compared with complex biologic medicines. Under the IRA, oral ...

The investigational drug, called PMD-026, is currently in phase 2 clinical trials for the treatment of breast cancer. Researchers at Washington University School of Medicine in St. Louis, MO, have ...

FTC Chair Lina Khan has the big three pharmacy benefit managers in sight—UnitedHealth's OptumRx, Cigna's Express Scripts and CVS Caremark Rx.

The report also sheds light on how PBMs give special treatment to the affiliated pharmacies ... A transformation in the PBM space will likely lead to fairer pricing and improved access to ...

The Federal Trade Commission (“FTC”) released its second interim report on Jan. 14, 2025, accusing pharmacy benefit managers (PBMs) of marking up the prices of specialty generic drugs. FTC’s report ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue through ...